A recent study by the Ovarian Tumor Tissue Analysis consortium (OTTA) focused on expression of ERα and the progesterone receptor (PR), and in a large series only strong expression of PR, but not ERα, was correlated to increased survival in high-grade serous ovarian cancer. The gene discussed is ESR1; the disease is ovarian serous adenocarcinoma.